Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Mise à jour : Il y a 4 ans
Référence : NCT00362583

Femme et Homme

  • | Pays :
  • Denmark
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary objectives: - To confirm the efficacy of intranasal fentanyl titrated to doses 50, 100 or 200 µg for treatment of breakthrough pain (BTP) in cancer patients - To establish long-term safety of treatment with intranasal fentanyl Secondary objectives: - To explore the relationship between dose of background opioid treatment and titrated fentanyl dose


Critère d'inclusion

  • Cancer

Liens